Prof. Carsten Marr is considered a pioneer in the field of AI-supported methods for improving the diagnosis and treatment of haematological diseases. "I want to bring AI methods closer to the patient and transfer them to clinical application," says Prof. Marr. He also wants to develop novel cell therapy approaches together with clinical research colleagues at the LMU Clinic. The close collaboration between Helmholtz Munich and LMU Klinikum creates ideal conditions for advancing translational research," says Prof. Dr. Dr. Michael von Bergwelt, Director of Medical Clinic III.

After studying theoretical physics at the Technical University of Munich and the Max Planck Institute of Quantum Optics, Prof. Marr turned to theoretical biology. His doctorate, which was awarded the annual prize at the TU Darmstadt, dealt with the architecture of biological networks. Research stays have taken him to Munich, Bremen and Edinburgh, among other places. In 2013, he founded his own research group at Helmholtz Munich and later became Deputy Director of the Institute of Computational Biology.

In interdisciplinary projects, Marr developed pioneering AI methods for biomedical applications - for example to predict stem cell decisions or to detect leukemia in blood smears. He has received numerous awards for his work on single-cell analysis, including an ERC Consolidator Grant.